Purchase Order 12305B22P0004

Award Date 12/2/21
Potential Completion Date 1/31/22
Potential Value $11K
Federal Agency
Northeast Area
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Calverton, MD 20705, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, by the Veterinary Services division of the U.S. Department of Veterans Affairs. The $10,463.01 contract is for the provision of Illumina's sequencing instruments, reagents, consumables, and maintenance services, which support critical genomic research and diagnostic initiatives across various federal agencies. Illumina holds two notable Indefinite...
This federal contract award to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency. The $20,198.50 firm fixed price purchase order does not have a set-aside designation. The contract is for the procurement of Illumina's advanced sequencing instruments, reagents, consumables, and bioinformatics software to support scientific research, healthcare, and...
This is a firm-fixed-price delivery order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. The $60,625.54 contract is for the procurement of Illumina's genetic sequencing platforms, reagents, consumables, and related services. The award does not utilize any set-aside designations. Illumina is a leading manufacturer of advanced genomic sequencing technologies and has been awarded...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $497,245.96, is for the provision of Illumina's genomic sequencing services and related products, including sequencing instruments like NextSeq, NovaSeq, and MiSeq systems, along with associated reagents, consumables, maintenance, and technical support. The contract does not...
This is a delivery order contract awarded by the National Institutes of Health (NIH) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $15,977.13, is for the procurement of Illumina's next-generation sequencing instruments, reagents, and related services. The contract does not have a set-aside designation and is a firm fixed-price type. Illumina has been awarded numerous prime federal contracts and grants across various...
This firm fixed-price purchase order contract was awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $150,974.70 contract is for a "MOLECULAR NEXT GENERATION SYSTEM" under an Other Transaction Authority (OT) agreement and does not have a set-aside designation. Illumina has previously received prime federal contracts and sub-grants from agencies like the National Institutes of Health, Centers...
This federal contract award, valued at $34,447.29, was issued by the Plains Area division of a civilian federal agency to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is a delivery order for the procurement of Illumina reagents, consumables, and related services, under the Major Program Code for "LABORATORY EQUIPMENT, CONSUMABLES AND SERVICES." The award has a firm fixed price pricing type and an ultimate completion date...
This firm fixed-price delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $12,058.24 contract is for the procurement of Illumina sequencing kits and does not have a set-aside designation. Illumina has been awarded multiple prime federal contracts and grants, primarily focused on providing advanced genomic sequencing...
This federal contract award to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency. The $116,138.74 firm fixed price delivery order contract is for the provision of Illumina's advanced sequencing instruments, reagents, consumables, and bioinformatics software to support the agency's genomic research and diagnostic initiatives. This award is part of a larger...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $157,400.64 contract is for the delivery of multi-ethnic genotyping kits, with a completion date of May 8, 2018. Illumina has a history of providing sequencing systems, reagents, and related services to federal agencies like the NIH, CDC, USDA, and VA for genomic...

This firm fixed-price purchase order was awarded by the Northeast Area of a civilian federal agency to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $11,166.80 contract is for the relocation of two Illumina instruments and associated maintenance services. No set-aside designation was used.

Illumina holds several Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs, including a $231,165 Blanket Purchase Agreement and a $1,297,062 Indefinite Delivery Contract. These IDVs enable the procurement of Illumina's sequencing platforms, reagents, maintenance, and bioinformatics products across multiple VA facilities to support the agency's genomic research and diagnostics initiatives. Illumina has been awarded numerous federal contracts and grants by agencies such as the NIH, CDC, USDA, VA, and FDA to provide advanced sequencing technologies and services for applications including infectious disease research, cancer diagnostics, environmental monitoring, and agricultural genetic analysis.

Generated 5/21/25, 9:52 AM